genetic disorders

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Gene Therapy's Hidden Engine: AAV Vector Market Poised to Explode 22% Annually Through 2034

AAV vector manufacturing market to surge from $874M (2025) to $5.2B (2034) as gene therapy breakthroughs drive demand for specialized production infrastructure.
TMOCRLLZAGYgene therapybiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Skeletal Dysplasia Market Set to Surge 54% to $5.37B by 2032

Global skeletal dysplasia market projected to grow from $3.48B (2026) to $5.37B (2032) at 7.42% CAGR, driven by diagnostic advances and innovative therapies.
PFENVSRAREREGNBMRNrare diseasebiologic therapy